Novel Bioconjugates As Therapeutic Agent and Synthesis Thereof
    1.
    发明申请
    Novel Bioconjugates As Therapeutic Agent and Synthesis Thereof 有权
    新型生物缀合物作为治疗剂及其合成

    公开(公告)号:US20090088372A1

    公开(公告)日:2009-04-02

    申请号:US12234233

    申请日:2008-09-19

    IPC分类号: A61K38/08 A61P31/12

    摘要: The present disclosure relates to a novel enzymatic approach according to the invention using an unprecedented sortase-catalyzed transpeptidation reaction between a substrate comprising LPXTG peptide motif and biomolecules such as aminosugars, hydroxyamino acids, hydroxyamino acid esters, aminolipids, polyamines; nucleic acids or derivatives thereof, or any molecule having such moieties; or any compound having such moieties to obtain a bioconjugates useful for target delivery of a compound. The present disclosure provides bioconjugates obtained by the novel sortase catalysed transpeptidedation reaction.

    摘要翻译: 本公开涉及根据本发明的新型酶促方法,其使用在包含LPXTG肽基序和生物分子如氨基糖,羟基氨基酸,羟基氨基酸酯,氨基脂肪,多胺的底物之间进行前所未有的分选酶催化的转肽反应; 核酸或其衍生物,或具有这些部分的任何分子; 或具有这种部分的任何化合物,以获得可用于目标递送化合物的生物缀合物。 本公开提供了通过新型分选酶催化的转肽反应获得的生物缀合物。